Regardless of the exposure to passive smoking variable (intensity or duration) used in the analyses, there was no evidence of heterogeneity in the association comparing ER+ and ER- (P > 0.05) or PR+ and PR- breast cancer (P > 0.05). This evidence concerns the gene ESR1 and breast carcinoma.